Industry-Wide GTIN Repository Planned by HDA and ValueCentric

Slated for launch in the third quarter of 2017, the repository is designed to facilitate DSCSA-mandated data exchange between manufacturers and their partners.

HDA is partnering with ValueCentric to build a central GTIN repository to ensure the efficient and accurate exchange of pharmaceutical product master data between manufacturers and their supply chain partners.
HDA is partnering with ValueCentric to build a central GTIN repository to ensure the efficient and accurate exchange of pharmaceutical product master data between manufacturers and their supply chain partners.

The Healthcare Distribution Alliance (HDA) has announced a new, long-term partnership with ValueCentric, LLC, to create a GTIN repository service designed for the efficient introduction of a GTIN coding system to help the industry meet DSCSA requirements.

HDA’s news release explains that “the purpose of this new service is to provide:

  • An easy-to-use central GTIN repository to ensure the efficient and accurate exchange of pharmaceutical product master data between manufacturers and their supply chain partners;

  • Further compliance with the DSCSA;

  • Real-time access to a self-service, cloud-based portal that allows for manufacturers to upload, update, and share product information quickly with their downstream partners; and,

  • A foundation for using product serialization data to advance industry logistics planning, analysis, and reporting.”

ValueCentric, a provider of channel data management and analytic solutions for the healthcare industry, was selected to collaborate with HDA to build and deliver the repository service because of its experience in managing complex data and relationships in the pharmaceutical supply chain.

Industry is already welcoming the efforts. Heather Zenk, VP of Global Secure Supply Chain Operations, AmerisourceBergen, said, “As we move toward the DSCSA serialization requirements, access to a GTIN database with real-time, reliable information will be crucial to meeting regulatory demands and to ensure pharmaceutical products move through the supply chain efficiently.” At HDA’s recent Traceability Seminar in Washington, D.C., HDA released results from its Pilot Study for Saleable Returns, which was designed to inform manufacturers and distributors in their efforts to comply with upcoming DSCSA requirements.

Participating in the service

HDA will solicit subscriptions for the repository during the first half of 2017; availability is planned for the third quarter of 2017. For additional information about the initiative and to learn how to participate, visit www.valuecentric.com/gtin.

Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
Medical Device Innovations Report
Cutting-edge packaging technologies are transforming the medical device sector in PMMI’s “Innovation in Medical Device” report, featuring advanced materials, smart solutions, and evolving regulations. Editors share insights from nearly 300 PACK EXPO booth visits—each product deemed new and truly innovative—alongside video demonstrations of the equipment and materials on display.
Learn More
Medical Device Innovations Report